Guardant Health, Inc.
Guardant Health, Inc. logo
GH

Guardant Health, Inc. (GH)

$53.812.67%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$49.6
Day's Range
$54.14
$27.65
52-Week Range
$103.92
1 month return13.84%
3 month return5.18%
1 year return39.34%
5 year return67.11%

Company Information

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.
OrganizationGuardant Health, Inc.
Employees1373
CEODr. Helmy Eltoukhy Ph.D.
IndustryHealth Services

Analyst Recommendation

based on 14 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 14 Wall street analysts offering stock ratings for Guardant Health, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 47.43%

Current

$53.81

Target

$79.33

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
12
21
20
Hold
2
3
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
5.4B
Book Value
$1.63
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.13
Wall Street Target Price
79.33

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
31.65
Enterprise Value
5.7B
Enterprise Value/Revenue
13.22
Enterprise Value/Ebitda
-10.31

Technicals

Beta
0.63
50 Day MA
49.75
200 Day MA
51.89

Institutional Holdings

FMR Inc

14.41%

Vanguard Group Inc

8.7%

Capital Research & Mgmt Co - Division 3

6.01%

Viking Global Investors LP

3.74%

ClearBridge Advisors, LLC

3.16%

Franklin Resources Inc

2.7%

Discover more

Frequently Asked Questions

What is Guardant Health, Inc. share price today?

Can Indians buy Guardant Health, Inc. shares?

How can I buy Guardant Health, Inc. shares from India?

Can Fractional shares of Guardant Health, Inc. be purchased?

What are the documents required to start investing in Guardant Health, Inc. stocks?

What are today’s High and Low prices of Guardant Health, Inc.?

What are today’s traded volumes of Guardant Health, Inc.?

What is today’s market capitalisation of Guardant Health, Inc.?

What is the 52 Week High and Low Range of Guardant Health, Inc.?

How much percentage Guardant Health, Inc. is down from its 52 Week High?

How much percentage Guardant Health, Inc. is up from its 52 Week low?

What are the historical returns of Guardant Health, Inc.?

Who is the Chief Executive Officer (CEO) of Guardant Health, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*